• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Outbreak of Candida auris infection in a COVID-19 hospital in Mexico

Mary Wilson

Well-known member
Hiram Villanueva-Lozano, Rogelio de J. Trevi?o-Rangel, Gloria M. Gonz?lez, Fernando Castilleja-Leal, Guillermo Torre-Amione, Michel F. Mart?nez-Res?ndez

Published:January 08, 2021 DOI:https://doi.org/10.1016/j.cmi.2020.12.030

Abstract

The aim of this study was to describe the clinical and microbiological characteristics of twelve patients with severe COVID-19 and Candida auris co-infection.
Microbiological characterization of the isolates consisting on molecular identification, genotypification through multilocus sequence typing and antifungal susceptibility to eight antifungals was performed.
Mortality among patients with COVID-19 and C. auris candidaemia was of 83.3% even with the use of appropriate antifungal therapy. All the isolates studied were resistant to amphotericin B.
Causes related to the incidence of COVID-19 and candidaemia are not well understood but seems to be related to common contributing factor seen in critically-ill patients; nonetheless, the high mortality reported demands close attention to patients who present this co-infection.

https://www.clinicalmicrobiologyand...743X(20)30790-4/fulltext#.X_nnze_OiQQ.twitter
 
Back
Top Bottom